SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-10-003772
Filing Date
2010-04-15
Accepted
2010-04-15 16:35:59
Documents
6
Period of Report
2010-05-13
Effectiveness Date
2010-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2197850zdef14a.htm DEF 14A 1547782
3 G701603.JPG g701603.jpg GRAPHIC 13485
4 G726892.JPG g726892.jpg GRAPHIC 5847
5 G600506.JPG g600506.jpg GRAPHIC 8685
6 G365122BEI001.GIF g365122bei001.gif GRAPHIC 85963
7 G365122BEI002.GIF g365122bei002.gif GRAPHIC 53100
  Complete submission text file 0001047469-10-003772.txt   1780052
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19319 | Film No.: 10752375
SIC: 2834 Pharmaceutical Preparations